Cloned T cells have been useful for assessing the lytic potential of distinct T cell subsets and for determining the relative contribution of different effector mechanism involved in the lytic process. Alloreactive CD8+ murine T cell clones and cloned murine CD4+ TH1 and TH2 T cells reactive with nominal antigen (ovalbumin) lysed nucleated target cells bearing antigen or coated with anti-CD3 monoclonal antibody in a short term51Cr-release assay. These clones were also evaluated for their ability to lyse efficiently sheep erythrocyte (SRBC) target cells coated with anti-CD3 mAb by a mechanism (presumably involving membrane damage) that does not involve nuclear degradation. Three patterns of lysis were observed: CD8+ and some CD4+ TH2 effector cells lysed efficiently nucleated target cells and anucleated SRBC coated with anti-CD3 mAb. However, CD4+ TH1 (and a few TH2) T cells which lysed nucleated target cells bearing antigen or coated with anti-CD3 mAb didnotlyse efficiently the SRBC coated with anti-CD3 mAb. One CD4 bearing TH2 cell failed to lyse efficiently either nucleated target cells or anucleated SRBC coated with anti-CD3 mAb. These results indicate that both TH1 and TH2 clones have lytic capabilities. Furthermore, they suggest that some but not all TH2 murine T cell clones have lytic characteristics similar to those of conventional CD8+ CTL. However, it is not certain how these patterns of lysis of target cellsin vitro relates to the capacity of CTL to lyse such target cellsin vivo.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
antibody-dependent cell-mediated cytotoxicity
antigen presenting cell
cytotoxic T lymphocyte
Fc receptor for IgG
helper T lymphocyte
major histocompatibility complex
mixed lymphocyte reaction
Lymphocyte Function antigen-1
sheep red blood cell
T cell receptor for antigen
Cerottini J-C, Brunner KT. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol 1974; 18: 67–132.
Perlmann P, Holm G. Cytotoxic effects of lymphoid cellsin vitro. Adv Immunol 1969; 11: 117–93.
Clark WR, Golstein P, eds. Mechanisms of cell-mediated cytotoxicity. New York: Plenum Press, 1982: 1–597.
Young JD. Killing of target cells by lymphocytes: a mechanistic view. Physiol Rev 1989; 69: 250–314.
Ostergaard HL, Kane KP, Mescher MF, Clark WR. Cytotoxic T lymphocytes mediated lysis without release of serine esterase. Nature 1987; 330: 71–2.
Trenn G, Takayama H, Sitkovsky MV. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes. Nature 1987; 330: 72–4.
Liu C-C, Steffan M, King F, Young JD-E. Identification, isolation, and characterization of a novel cytotoxin in murine cytolytic lymphocytes. Cell 1987; 51: 393–403.
Lancki DW, Kaper BP, Fitch FW. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis but only selectively inhibits TCR-mediated lytic activity by cloned CTL. J Immunol 1989; 142: 416–24.
Wagner H, Starzinski-Powitz A, Jung H, Röllinghoff M. Induction of I region-restricted hapten-specific cytotoxic T lymphocytes. J Immunol 1977; 119: 1365–8.
Moretta A, Mingari MC, Haynes BF, Sekaly RP, Moretta L, Fauci AS. Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture. J Exp Med 1981; 153: 213–8.
Swain SL, Dennert G, Wormsley S, Dutton RW. The Lyt phenotype of a long-term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly-1 cells. Eur J Immunol 1981; 11: 175–80.
Tite JP, Janeway CA Jr. Cloned helper T cells can kill B lymphoma cells in the presence of specific antigen: Ia restriction and cognate vs. non cognate interactions in cytolysis. Eur J Immunol 1984; 14: 878–86.
Vidovic D, Juretic A, Nagy ZA, Klein J. Lyt Phenotypes of primary cytotoxic T cells generated across the A and E region of the H-2 complex. Eur J Immunol 1981; 11: 499–504.
Ball EJ, Stasny P. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets. Immunogenetics 1982; 16: 157–69.
Shinohara N, Kojima M. Mouse alloantibodies capable of blocking cytotoxic T cell function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to anti-Lyt-2 blocking. J Immunol 1984; 132: 578–83.
Spits H, Ijssel H, Thompson A, De Vries JE. Human T4+ and T8+ cytotoxic T lymphocyte clones directed at products of different class II major histocompatibility complex loci. J Immunol 1983; 131: 678–82.
Meuer SC, Hodgdon JC, Cooper DA, Hussey RE, Fitzgerald KA, Schlossman SF, Reinherz EL. Human cytotoxic T cell clones directed at autologous virus-transformed targets: Further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. J Immunol 1983; 131: 186–90.
Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt Verhulst A-M, Pierres M. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of la-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3−, and T4−, Lyt-2,3−) subsets among anti-Ia cytolytic T cell clones. J Immunol 1984; 132: 2775–82.
Swain SL, Panfili PR. Helper cells activated by allogenic H-2K or H-2D differences have a Ly phenotype distinct from those responsive to I differences. J Immunol 1979; 122: 383–91.
Fong TA, Mosmann TR. Alloreactive murine CD8+ T cell clones secrete the Thl pattern of cytokines. J Immunol 1990; 144: 1744–52.
Kim KJ, Kanellopoulos-Langevin C, Merwin RM, Sachs DH, Asofsky R. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 1979; 122: 549–54.
Glimcher LH, Sharrow SO, Paul WE. Serologic and functional characterization of a panel of antigen-presenting cell lines expressing mutant I-A class II molecules. J Exp Med 1983; 158: 1573–88.
Spits H, van Schooten W, Keizer H, van Seventer G, van de Rijn M, Terhorst C, De Vries JE. Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. Science 1986; 232: 403–5.
Blanchard D, Van Els C, Aubry JP, De Vries JE, Spits H. CD4 is involved in a post-binding event in the cytolytic reaction mediated by human CD4+cytotoxic T lymphocyte clones. J Immunol 1988; 140: 1745–52.
Bank I, Chess L. Perturbation of the T4 molecule transmits a negative signal to T cells. J Exp Med 1985; 162: 1294–303.
Saizawa K, Rojo J, Janeway CA Jr: Evidence for a physical association of CD4 and the CD3α⨿T-cell. Nature 1987; 328: 260–3.
Palacios R, Martinez-Maza O. Is the E receptor on human T lymphocytes a “negative signal receptor”?. J Immunol 1982; 129: 2479–85.
Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA, Hodgdon JC, Protentis JP, Schlossman SF, Reinherz EL. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 1984; 36: 897–906.
Golding H, Munitz TI, Singer A. Characterization of antigen-specific, la-restricted, L3T4+ cytolytic T lymphocytes and assessment of thymic influence on their self specificity. J Exp Med 1985; 162: 943–61.
Kaplan DR, Griffith R, Braciale VL, Braciale TJ. Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products. Cell Immunol 1984; 88: 193–206.
Erb P, Grogg D, Troxler M, Kennedy M, Fluri M. CD4+ T cell-mediated killing of MHC class II-positive antigenpresenting cells. I. Characterization of target cell recognition byin vivo orin vitro activated CD4+ killer T cells. J Immunol 1990; 144: 790–5.
Lancki DW, Lorber MI, Loken MR, Fitch FW. A clone specific monoclonal antibody which inhibits T cell-mediated cytolysis. Adv Exp Med Biol 1982; 146: 557–62.
Meuer SC, Hodgdon JC, Hussey RE, Protentis JP, Schlossman SF, Reinherz EL. Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med 1983; 158: 988–93.
Ertl HCJ, Greene MI, Noseworthy JH, Fields BN, Nepom JT, Spriggs DR, Finberg RW. Identification of idiotypic receptors on reovirus- specific cytolytic T cells. Proc Natl Acad Sci USA 1982; 79: 7479–83.
Lancki DW, Ma DI, Havran WL, Fitch FW. Cell surface structures involved in T cell activation. Immunol Rev 1984; 81: 65–94.
Staerz UD, Kanagawa O, Bevan MJ. Hybrid antibodies can target sites for attack by T cells. Nature 1985; 314: 628–31.
Spits H, Yssel H, Leeuwenberg J, De Vries JE. Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. Eur J Immunol 1985; 15: 88–91.
Leo O, Sachs DH, Samelson LE, Foo M, Quinones R, Gress R, Bluestone JA. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. J Immunol 1986; 137: 3874–80.
Hsi ED, Siegel JN, Minami Y, Luong ET, Klausner RD, Samelson LE. T cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J Biol Chem 1989; 264: 10836–42.
MacDonald HR, Thiernesse N, Cerottini J-C. Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2. Heterogeneity of inhibition at the clonal level. J Immunol 1981; 126: 1671–5.
Gajewski TF, Joyce J, Fitch FW. Anti-proliferatine effect of IFN-γ in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-γ. J Immunol 1989; 143: 15–22.
Dennert G, Anderson CG, Prochazka G. High activity ofNα-benzylocarbonyl-L-lysine thiobenzyl ester serine esterase and cytolytic perforin in cloned cell lines is not demonstrable inin vivo-induced cytotoxic effector cells. Proc Natl Acad Sci USA 1987; 84: 5004–8.
Häyry P, Anderson LC. Generation of T memory cells in one-way mixed lymphocyte culture. IV Primary and secondary responses to soluble and insoluble membrane preparations and to ultraviolet-light-inactivated stimulator cells. Scand J Immunol 1976; 5: 391–9.
Berke G, Rosen D. Are lytic granules and perform 1 involved in lysis induced byin vivo-primed peritoneal exudate cytolytic T lymphocytes. Transplant Proc 1987; 19: 412–16.
Berke G, Rosen D. Highly lyticin vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformationin vitro. J Immunol 1988; 141: 1429–36.
Brooks CG, Urdal DL, Henney CS. Lymphokine-driven “differentiation” of cytotoxic T-cell clones into cells with NK-like specificity: Correlations with displays of membrane macromolecules. Immunol Rev 1983; 72: 43–72.
Havele C, Bleackley RC, Paetkau V Conversion of specific to nonspecific cytotoxic T lymphocytes. J Immunol 1986; 137: 1448–54.
Möller G ed. Molecular mechanisms of T cell-mediated lysis. Immunol Rev 1988; 103: 1–211.
Schmid DS, Tite JP, Ruddle NH. DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. Proc Natl Acad Sci USA 1986; 83: 1881–5.
Tite JP, Powell MB, Ruddle NH. Protein-antigen specific Ia-restricted cytolytic T cells: Analysis of frequency, target cell susceptibility, and mechanism of cytolysis. J Immunol 1985; 135: 25–33.
Ju ST, Ruddle NH, Strack P, Dorf ME, DeKruyff RH. Expression of two distinct cytolytic mechanisms among murine CD4 subsets. J Immunol 1990; 144: 23–31.
Henney CS. Studies on the mechanism of lymphocyte-mediated cytolysis. J Immunol 1973; 110: 73–84.
Poenie M, Tsien RY, Schmitt Verhulst AM. Sequential activation and lethal hit measured by [Ca2+]; in individual cytolytic T cells and targets. EMBO J 1987; 6: 2223–32.
Dourmashkin RR, Deteix P, Simone CB, Henkart P. Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity. Clin Exp Immunol 1980; 42: 554–60.
Dennert G, Podack ER. Cytolysis by H-2 specific T killer cells. Assembly of tubular complexes on target membranes. J Exp Med 1983; 157: 1483–95.
Lanzavecchia A, Staerz UD. Lysis of nonnucleated red blood cells by cytotoxic T lymphocytes. Eur J Immunol 1987; 17: 1073–4.
Glasebrook AL, Fitch FW. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med 1980; 151: 876–95.
Lancki DW, Hsieh C-S, Fitch FW. Mechanisms of lysis by Cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. J. Immunol 1991; 146: 3242–49.
Henkart MP, Henkart PA. Lymphocyte mediated cytolysis as a secretory phenomenon. Adv Exp Med Biol 1982; 146: 227–47.
Chang TW, Eisen HN. Effects of N alpha-tosyl-L-lysyslchloromethylketone on the activity of cytotoxic T lymphocytes. J Immunol 1980; 124: 1028–33.
Takayama H, Sitkovsky MV. Antigen receptor-regulated exocytosis in cytoxic T lymphocytes. J Exp Med 1987; 166: 725–43.
Tirosh R, Berke G. T-Lymphocyte-mediated cytolysis as an excitatory process of the target. I. Evidence that the target cell may be the site of Ca2+ action. Cell Immunol 1985; 95: 113–23.
Russell JH. Internal disintegration model of cytolytic lymphocyte-induced target damage. Immunol Rev 1983; 72: 97–118.
Conta BS, Powell MB, Ruddle NH. Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: Stimulation of proliferation, lymphokine production, and self-destruction. J Immunol 1985; 134; 2185–90.
Jongeneel CV, Nedospasov SA, Plaetinck G, Naquet P, Cerottini JC. Expression of the tumor necrosis factor locus is not necessary for the cytolytic activity of T lymphocytes. J Immunol 1988; 140: 1916–22.
About this article
Cite this article
Lancki, D.W., Fitch, F.W. Cytolytic T lymphocytes: an overview of their characteristics. Biotherapy 5, 71–81 (1992). https://doi.org/10.1007/BF02194787
- Anti-TCR mAb
- Cytotoxic T lymphocytes
- mAb coated target cells
- mechanisms of lysis
- T cell clones